Abstract:
Modified HCV non-structural proteins are described. The proteins include modified NS3 domains such that proteolytic activity of the NS3 molecule is inhibited. The modified proteins retain conformational epitopes. HCV immunoassays including the modified NS3 molecules are also described.
Abstract:
Various embodiments of the invention provide human immune response associated proteins (IRAP) and polynucleotides which identify and encode IRAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of IRAP.
Abstract:
Various embodiments of the invention provide human cell adhesion and extracellular matrix proteins (CADECM) and polynucleotides which identify and encode CADECM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CADECM.
Abstract:
Various embodiments of the invention provide human receptors and membrane-associated proteins (REMAP) and Q polynucleotides which identify and encode REMAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP.
Abstract:
An adapter with interchangeable plug board (3) that can be easily interchanged for various types of receptacles is provided. The adapter includes a casing (1), a cover (2), and a plug board (3). The casing (1) is formed with first insetting means such as a plurality of slots (13, 14b, 14c). In addition, an upright slide slot (16) is formed on one sidewall of the casing (1). A sliding piece (17) is slidably inset in the slide slot (16). The sliding piece (17) is formed with a stop tongue (170) on the top and is lockable at least at a top position and a lower position. The plug board (3) has a base board (30) and a plurality of plug pins (31) erected thereon. Further, the base board (30) is formed with second insetting means such as a plurality of tongues (33, 34) for forming a tongue-and-slot joint with the first insetting means on the casing (1). A stop slot (35) is formed near the rear edge of the base board (30). The first and second insetting means allow the plug board (3) to be easily mounted in position in the casing (1). The sliding piece (17) allows the plug board (3) to be locked in position in the casing (1), and also allows the plug board (3) to be easily detached from the casing (1) for replacement with another plug board.
Abstract:
Systems and methods for imaging a 3D volume of geometrically irregular grid data. The systems and methods utilize various types of probes and displays to render the geometrically irregular grid data, in real-time, and analyze the geometrically irregular grid data.
Abstract:
Modified HCV multiple epitope fusion antigens (MEFAs) are described. The proteins include modified sequences such that proteolytic cleavage of the MEFAs by HCV NS3 protease is inhibited. HCV immunoassays including the modified MEFAs are also described.
Abstract:
Systems and methods for imaging a 3D volume of geometrically irregular grid data. The systems and methods utilize various types of probes and displays to render the geometrically irregular grid data, in real-time, and analyze the geometrically irregular grid data.
Abstract:
Peptide reagents that interact preferentially with the PrPsc form of the prion protein are described. Methods of using the reagents for isolation and purification of the PrPsc isoform are described.